Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Nov;40(5):710–718. doi: 10.1038/bjc.1979.251

Tumour markers in breast cancer.

D H Cove, K L Woods, S C Smith, D Burnett, J Leonard, R J Grieve, A Howell
PMCID: PMC2010109  PMID: 92331

Abstract

The clinical usefulness of 8 potential tumour markers has been evaluated in 69 patients with Stage I and II breast cancer and 57 patients with Stage III and IV. Serum CEA concentrations were raised in 13% of patients with local and 65% of those with advanced breast cancer. In patients with clinical evidence of progression or regression of tumour, serum CEA levels changed appropriately in 83% of cases. Taking 4 of the markers (carcinoembryonic antigen (CEA), lactalbumin, alpha subunit and haptoglobin) serum concentrations of one or more were raised in 33% of patients with local disease and 81% of those with advanced breast cancer. However, marker concentrations were often only marginally raised, and are unlikely to provide sensitive guide to tumour burden. CEA, lactalbumin and alpha subunit were detectable in 68%, 43% and 40% respectively of extracts of primary breast cancers.

Full text

PDF
710

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. M., Stimson W. H., Kelly F. Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin. Br J Surg. 1976 Oct;63(10):819–822. doi: 10.1002/bjs.1800631022. [DOI] [PubMed] [Google Scholar]
  2. Bagshawe K. D. Radioimmunoassay and saturation analysis. Tumor-associated antigens. Br Med Bull. 1974 Jan;30(1):68–73. doi: 10.1093/oxfordjournals.bmb.a071170. [DOI] [PubMed] [Google Scholar]
  3. Booth S. N., Jamieson G. C., King J. P., Leonard J., Oates G. D., Dykes P. W. Carcinoembryonic antigen in management of colorectal carcinoma. Br Med J. 1974 Oct 26;4(5938):183–187. doi: 10.1136/bmj.4.5938.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chu T. M., Nemoto T. Evaluation of carcinoembryonic antigen in human mammary carcinoma. J Natl Cancer Inst. 1973 Oct;51(4):1119–1122. doi: 10.1093/jnci/51.4.1119. [DOI] [PubMed] [Google Scholar]
  5. Coombes R. C., Hillyard C., Greenberg P. B., MacIntyre I. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet. 1974 Jun 1;1(7866):1080–1083. doi: 10.1016/s0140-6736(74)90557-1. [DOI] [PubMed] [Google Scholar]
  6. Coombes R. C., Powles T. J., Gazet J. C., Ford H. T., Sloane J. P., Laurence D. J., Neville A. M. Biochemical markers in human breast cancer. Lancet. 1977 Jan 15;1(8003):132–134. doi: 10.1016/s0140-6736(77)91719-6. [DOI] [PubMed] [Google Scholar]
  7. Cove D. H., Smith S. C., Walker R., Howell A. The synthesis of the glycoprotein hormone alpha subunit by human breast carcinomas. Eur J Cancer. 1979 May;15(5):693–702. doi: 10.1016/0014-2964(79)90143-9. [DOI] [PubMed] [Google Scholar]
  8. Goldenberg D. M., DeLand F., Kim E., Bennett S., Primus F. J., van Nagell J. R., Jr, Estes N., DeSimone P., Rayburn P. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med. 1978 Jun 22;298(25):1384–1386. doi: 10.1056/NEJM197806222982503. [DOI] [PubMed] [Google Scholar]
  9. Hendrick J. C., Franchimont P. Radio-immunoassay of casein in the serum of normal subjects and of patients with various malignancies. Eur J Cancer. 1974 Nov;10(11):725–730. doi: 10.1016/0014-2964(74)90111-x. [DOI] [PubMed] [Google Scholar]
  10. Horne C. H., Reid I. N., Milne G. D. Prognostic significance of inappropriate production of pregnancy proteins by breast cancers. Lancet. 1976 Aug 7;2(7980):279–282. doi: 10.1016/s0140-6736(76)90731-5. [DOI] [PubMed] [Google Scholar]
  11. Laurell C. B. Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972;124:21–37. doi: 10.3109/00365517209102748. [DOI] [PubMed] [Google Scholar]
  12. Lieblich J. M., Weintraub B. D., Rosen S. W., Chou J. Y., Robinson J. C. HeLa cells secrete alpha subunit of glycoprotein tropic hormones. Nature. 1976 Apr 8;260(5551):530–532. doi: 10.1038/260530a0. [DOI] [PubMed] [Google Scholar]
  13. Mittra I., Hayward J. L. Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet. 1974 May 11;1(7863):885–889. doi: 10.1016/s0140-6736(74)90344-4. [DOI] [PubMed] [Google Scholar]
  14. Monaco M. E., Bronzert D. A., Tormey D. C., Waalkes P., Lippman M. E. Casein production by human breast cancer. Cancer Res. 1977 Mar;37(3):749–754. [PubMed] [Google Scholar]
  15. Ravry M., Moertel C. G., Schutt A. J., Go V. L. Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma. Cancer. 1974 Oct;34(4):1230–1234. doi: 10.1002/1097-0142(197410)34:4<1230::aid-cncr2820340432>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  16. Sheth N. A., Suraiya J. N., Sheth A. R., Ranadive K. J., Jussawalla D. J. Ectopic production of human placental lactogen by human breast tumors. Cancer. 1977 Apr;39(4):1693–1699. doi: 10.1002/1097-0142(197704)39:4<1693::aid-cncr2820390445>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  17. Steward A. M., Nixon D., Zamcheck N., Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer. 1974 May;33(5):1246–1252. doi: 10.1002/1097-0142(197405)33:5<1246::aid-cncr2820330509>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  18. Stimson W. H. Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet. 1975 Apr 5;1(7910):777–779. doi: 10.1016/s0140-6736(75)92439-3. [DOI] [PubMed] [Google Scholar]
  19. Tormey D. C., Waalkes T. P., Ahmann D., Gehrke C. W., Zumwatt R. W., Snyder J., Hansen H. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides. Cancer. 1975 Apr;35(4):1095–1100. doi: 10.1002/1097-0142(197504)35:4<1095::aid-cncr2820350412>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  20. Tormey D. C., Waalkes T. P., Snyder J. J., Simon R. M. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer. 1977 Jun;39(6):2397–2404. doi: 10.1002/1097-0142(197706)39:6<2397::aid-cncr2820390614>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  21. Woods K. L., Cove D. H., Howell A. Predictive classification of human breast carcinomas based on lactalbumin synthesis. Lancet. 1977 Jul 2;2(8027):14–16. doi: 10.1016/s0140-6736(77)90006-x. [DOI] [PubMed] [Google Scholar]
  22. Woods K. L., Cove D. H., Morrison J. M., Heath D. A. The investigation of lactalbumin as a possible marker for human breast cancer. Eur J Cancer. 1979 Jan;15(1):47–51. doi: 10.1016/0014-2964(79)90204-4. [DOI] [PubMed] [Google Scholar]
  23. Woods K. L., Heath D. A. The interference of endogenous antibodies to bovine lactalbumin in the radioimmunoassay of human lactalbumin in serum. Clin Chim Acta. 1978 Mar 1;84(1-2):207–211. doi: 10.1016/0009-8981(78)90496-5. [DOI] [PubMed] [Google Scholar]
  24. Woods K. L., Heath D. A. The radioimmunoassay of human lactalbumin. Clin Chim Acta. 1977 Jul 1;78(1):129–133. doi: 10.1016/0009-8981(77)90345-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES